Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity

Cell(2021)10.1016/j.cell.2021.01.037Source: DataRank Database

Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity is a research paper published in Cell (2021). On theSindex it has a DataRank of 0.974. It has been cited 660 times.

N/A

0.974DataRank · unranked

Scored on demand from live citation data

Open Access660 citations

Download PDF

Cite:

Linked data & code

gen refseq uniprot pdb doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (31 grants)Impact (FWCI 39.14)OA: hybridTopics (37)IDs (PubMed, PMC, OpenAlex)Annotations (5)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.974

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (66)

Laura E. Rosen ORCID,James G. Shepherd ORCID,Roberto Spreafico ORCID,Ana da Silva Filipe ORCID,Jason A. Wojcechowskyj ORCID

Live enrichment

PubMed:33621484 PMC:PMC7843029 OpenAlex:https://openalex.org/W3127277789

Wellcome Trust

Grant: 206298/Z/17/Z

Academy of Medical Sciences

Grant: AMS-CSF4-Torok

Medical Research Council

Grant: MC_UU_12014/3

Biotechnology and Biological Sciences Research Council

Grant: BBS/E/D/20002173

Medical Research Council

Grant: HDRUK2021.0125

National Institute for Health Research (NIHR)

Grant: NIHR201395

NCI NIH HHS

Grant: P30 CA008748

Biotechnology and Biological Sciences Research Council

Grant: BBS/E/D/30002277

Medical Research Council

Grant: MC_PC_19059

Medical Research Council

Grant: MC_PC_19025

Medical Research Council

Grant: MC_UU_12014/10

NIGMS NIH HHS

Grant: R01 GM121505

Wellcome Trust

Grant: 209407/Z/17/Z

National Institute for Health Research (NIHR)

Grant: CO-CIN-01

Medical Research Council

Grant: MC_UU_12014/12

Medical Research Council

Grant: MR/S032304/1

Wellcome Trust

Grant: 201366/Z/16/Z

Wellcome Trust

Grant: 215091/Z/18/Z

Medical Research Council

Grant: MC_UU_12014/9

NIGMS NIH HHS

Grant: P30 GM124169

Chief Scientist Office

Grant: COV/EDI/20/11

Medical Research Council

Grant: MC_PC_19027

National Institute for Health Research (NIHR)

Grant: NIHR300669

NIGMS NIH HHS

Grant: R01 GM132386

Medical Research Council

Grant: 2294377

NIH

National Institute for Health Research (NIHR)

Wellcome Trust

Bill and Melinda Gates Foundation

Medical Research Council

NSF

FWCI

39.14

Citation Percentile

1.0%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

hybridLicense: cc-by

journalhttp://www.cell.com/article/S0092867421000805/pdf

publisherhttp://www.cell.com/article/S0092867421000805/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0092867421000805?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0092867421000805?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.cell.2021.01.037

Fields of Study

SARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approachesMonoclonal and Polyclonal Antibodies Research

MeSH Terms

Angiotensin-Converting Enzyme 2COVID-19SARS-CoV-2Antibodies, ViralHumansMutationPhylogenyVirulenceGenetic FitnessImmune EvasionAntibodies, NeutralizingSpike Glycoprotein, Coronavirus

Keywords

BiologySpike (software development)ImmunitySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Spike ProteinCoronavirus disease 2019 (COVID-19)AntibodyVirology2019-20 coronavirus outbreakGeneticsImmune systemDiseaseOutbreakMutationVariantspikeprotein structureCovid-19Sars-cov-2Receptor Binding MotifMonoclonal Antibody EscapeN439k

Sustainable Development Goals

SDG 0: Good health and well-being

Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity

FAIR Checklist

DataRank Breakdown

Authors (66)

Funding (31 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)